References
- PoortmansPEvidence-based radiation oncologyBreast cancer. Radio-ther Oncol20078484101
- ClarkeMCollinsRDarbySEffects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trialsLancet20053662087210616360786
- FisherBAndersonSRedmondCKWolmarkNWickerhamDLCroninWMReanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancerN Engl J Med199533322145614617477145
- XsQWhiteJXaLIs alpha/beta for breast cancer really low?Radiother Oncol201110028228821367477
- EvansPMDonovanEMPartridgeMThe delivery of intensity modulated radiotherapy to the breast using multiple static fieldsRadiother Oncol2000571798911033192
- FletcherGHHypofractionation: lessons from complicationsRadiother Oncol199120110152020750
- OwenJRAshtonABlissJMEffect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trialLancet Oncol20067646747116750496
- HavilandJSOwenJRDewarJAThe UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trialsLancet Oncol2013141086109424055415
- WhelanTJPignolJPLevineMNLong-term results of hypofractionated radiation therapy for breast cancerN Engl J Med2010362651352020147717
- SmithBDBentzenSMCorreaCRFractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guidelineInt J Radiat Oncol Biol Phys2011811596820638191
- JagsiRGriffithKABoikeTPDifferences in the acute toxic effects of breast radiotherapy by fractionation schedule: comparative analysis of physician-assessed and patient-reported outcomes in a large multicenter cohortJAMA Oncol, published online2015
- MorgantiAGCillaSValentiniVPhase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patientsRadiother Oncol2009901869219010560
- CoxJDStetzJPajakTFToxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)Int J Radiat Oncol Biol Phys1995315134113467713792
- YarnoldJAshtonABlissJFractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trialRadiother Oncol200575191715878095
- BuwengeMCammelliSAmmendoliaIIntensity modulated radiation therapy for breast cancer: current perspectivesBreast Cancer2017912112628293119
- MorgantiAGCillaSde GaetanoAForward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When?J Appl Clin Med Phys2011122345122221587195
- HarsoliaAKestinLGrillsIIntensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapyInt J Radiat Oncol Biol Phys20076851375138017544598
- McdonaldMWGodetteKDButkerEKDavisLWJohnstonePALong-term outcomes of IMRT for breast cancer: a single-institution cohort analysisInt J Radiat Oncol Biol Phys20087241031104018440727
- PignolJPTruongPRakovitchESattlerMGWhelanTJOlivottoIATen years results of the Canadian breast intensity modulated radiation therapy (IMRT) randomized controlled trialRadiother Oncol2016121341441927637858
- YarnoldJRadiation therapy in treating women who have undergone breast conservation surgery and systemic therapy for early breast cancer Available from: http://clinicaltrials.gov/show/NCT00818051. NLM identifier NCT00818051Accessed February 26, 2018
- ViciniFHigher per daily treatment-dose radiation therapy or standard per daily treatment radiation therapy in treating patients with early-stage breast cancer that was removed by surgery Available from: http://clinicaltrials.gov/show/NCT01349322. NLM identifier NCT01349322Accessed February 26, 2018